Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial

Author:

Kijak Gustavo H.12,Tovanabutra Sodsai12,Rerks-Ngarm Supachai3,Nitayaphan Sorachai4,Eamsila Chirapa4,Kunasol Prayura3,Khamboonruang Chirasak3,Thongcharoen Prasert3,Namwat Chawetsan3,Premsri Nakorn3,Benenson Michael4,Morgan Patricia4,Bose Meera12,Sanders-Buell Eric12,Paris Robert4,Robb Merlin L.12,Birx Deborah L.2,De Souza Mark S.14,McCutchan Francine E.12,Michael Nelson L.2,Kim Jerome H.2

Affiliation:

1. U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA

2. U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA

3. Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand

4. Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand

Abstract

ABSTRACT The RV144 HIV-1 vaccine trial (Thailand, 2003 to 2009), using immunogens genetically matched to the regional epidemic, demonstrated the first evidence of efficacy for an HIV-1 vaccine. Here we studied the molecular evolution of the HIV-1 epidemic from the time of immunogen selection to the execution of the efficacy trial. We studied HIV-1 genetic diversity among 390 volunteers who were deferred from enrollment in RV144 due to preexisting HIV-1 infection using a multiregion hybridization assay, full-genome sequencing, and phylogenetic analyses. The subtype distribution was 91.7% CRF01_AE, 3.5% subtype B, 4.3% B/CRF01_AE recombinants, and 0.5% dual infections. CRF01_AE strains were 31% more diverse than the ones from the 1990s Thai epidemic. Sixty-nine percent of subtype B strains clustered with the cosmopolitan Western B strains. Ninety-three percent of B/CRF01_AE recombinants were unique; recombination breakpoint analysis showed that these strains were highly embedded within the larger network that integrates recombinants from East/Southeast Asia. Compared to Thai sequences from the early 1990s, the distance to the RV144 immunogens increased 52% to 68% for CRF01_AE Env immunogens and 12% to 29% for subtype B immunogens. Forty-three percent to 48% of CRF01_AE sequences differed from the sequence of the vaccine insert in Env variable region 2 positions 169 and 181, which were implicated in vaccine sieve effects in RV144. In conclusion, compared to the molecular picture at the early stages of vaccine development, our results show an overall increase in the genetic complexity of viruses in the Thai epidemic and in the distance to vaccine immunogens, which should be considered at the time of the analysis of the trial results.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference85 articles.

1. HIV diversity, molecular epidemiology, and the role of recombination

2. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease

3. KuikenC LeithnerT HahnB MullinsJ WolinskyS FoleyB ApetreiC MizrahiI RambautA KorberB. 2012. HIV sequence compendium 2012. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM.

4. The Challenge of HIV-1 Subtype Diversity

5. TovanabutraS BirxD McCutchanF. 2004. Molecular epidemiology of HIV in Asia and the Pacific. In LuY EssexM (ed), AIDS in Asia. Kluwer Academic, New York, NY.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3